HTG Molecular Diagnostics, Inc.
HTGMQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$221
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $221.00 |
|---|---|
| Enterprise Value | $984,522.00 |
| Earnings per Share | $-24.28 |
| Beta | 3.41 |
| Outstanding Shares | 2,214,082 |
Return
| Return on Equity | -4246.92% |
|---|---|
| Return on Assets | -185.46% |
| Return on Invested Capital | -460.72% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.16 |
| Enterprise Value to EBIT | -0.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 4.04 |
| Debt to Equity | 8.39 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-$11.80
Consensus analyst estimateRevenue Estimate
$1.60 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
-$11.80
Consensus analyst estimateRevenue Estimate
$1.60 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About HTG Molecular Diagnostics, Inc.
53 employees
CEO: John L. Lubniewski
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed mo...